WFRF:(Line Pal Dag)
Sökning: WFRF:(Line Pal Dag) > Chemotherapy or Liv...
- Dueland, Svein (författare)
Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?
- Artikel/kapitelEngelska2015
Förlag, utgivningsår, omfång ...
- 2015
- printrdacarrier
Nummerbeteckningar
- LIBRIS-ID:oai:DiVA.org:uu-252158
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-252158URI
- https://doi.org/10.1097/SLA.0000000000000786DOI
Kompletterande språkuppgifter
- Språk:engelska
- Sammanfattning på:engelska
Ingår i deldatabas
- SwePubSwePub
Klassifikation
Anmärkningar
- Objective: The primary objective was to compare overall survival (OS) in patients with colorectal cancer (CRC) with nonresectable liver-only metastases treated by liver transplantation or chemotherapy. Background: CRC is the third most common cancer worldwide. About 50% of patients will develop metastatic disease primarily to the liver and the lung. The majority of patients with liver metastases receive palliative chemotherapy, with a median OS of trial patients of about 2 years, and less than 10% are alive at 5 years. Methods: Patients with nonresectable liver-only CRC metastases underwent liver transplantation in the SECA study (n = 21). Disease-free survival (DFS) and OS of patients included in the SECA study were compared with progression-free survival (PFS) and OS in a similar cohort of CRC patients with liver-only disease included in a first-line chemotherapy study, the NORDIC VII study (n = 47). PFS/DFS and OS were estimated by the Kaplan-Meier method. Results: DFS/PFS in both groups were 8 to 10 months. However, a dramatic difference in OS was observed. The 5-year OS rate was 56% in patients undergoing liver transplantation compared with 9% in patients starting first-line chemotherapy. The reason for the large difference in OS despite similar DFS/PFS is likely different metastatic patterns at relapse/progression. Relapse in the liver transplantation group was often detected as small, slowly growing lung metastases, whereas progression of nonresectable liver metastases was observed in the chemotherapy group. Conclusions: Compared with chemotherapy, liver transplantation resulted in a marked increased OS in CRC patients with nonresectable liver-only metastases.
Ämnesord och genrebeteckningar
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Kirurgi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Surgery hsv//eng
- chemotherapy
- colorectal cancer
- liver metastases
- liver transplantation
- overall survival
Biuppslag (personer, institutioner, konferenser, titlar ...)
- Guren, Tormod K. (författare)
- Hagness, Morten (författare)
- Glimelius, BengtUppsala universitet,Enheten för onkologi(Swepub:uu)bengglim (författare)
- Line, Pal-Dag (författare)
- Pfeiffer, Per (författare)
- Foss, Aksel (författare)
- Tveit, Kjell M. (författare)
- Uppsala universitetEnheten för onkologi (creator_code:org_t)
Sammanhörande titlar
- Ingår i:Annals of Surgery261:5, s. 956-9600003-49321528-1140
Internetlänk
Hitta mer i SwePub
- Av författaren/redakt...
- Dueland, Svein
- Guren, Tormod K.
- Hagness, Morten
- Glimelius, Bengt
- Line, Pal-Dag
- Pfeiffer, Per
- visa fler...
- Foss, Aksel
- Tveit, Kjell M.
- visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Kirurgi
- Artiklar i publikationen
- Annals of Surger ...
- Av lärosätet
- Uppsala universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
